EVO

Evotec SE American Depositary Shares (EVO)

About Evotec SE American Depositary Shares (EVO)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Details

Daily high
$3.14
Daily low
$3.08
Price at open
$3.14
52 Week High
$12.00
52 Week Low
$2.85
Market cap
1.1B
Dividend yield
0.00%
Volume
65,823
Avg. volume
97,902
P/E ratio
-6.13

Evotec SE American Depositary Shares News

Details

Daily high
$3.14
Daily low
$3.08
Price at open
$3.14
52 Week High
$12.00
52 Week Low
$2.85
Market cap
1.1B
Dividend yield
0.00%
Volume
65,823
Avg. volume
97,902
P/E ratio
-6.13